Working to Eradicate Gynecologic Cancers

98 - Featured Poster
Phase I trial results of a folate receptor alpha-directed cancer vaccine (E39) in ovarian and endometrial cancer patients to prevent recurrence

Monday, March 24, 2014: 7:18 AM
Room 13-16 (Tampa Convention Center)
K. A. Byrd1, E. Schneble2, S. Ponniah3, W. P. McGuire4, T. P. Conrads5, J. C. Elkas6, K. M. Darcy5, G. L. Maxwell4, C. A. Hamilton7 and G. Peoples2
1Naval Medical Center Portsmouth, Portsmouth, VA, 2San Antonio Military Medical Center, Ft Sam Houston, TX, 3Uniformed Services University of the Health Sciences, Bethesda, MD, 4Inova Fairfax Hospital, Falls Church, VA, 5Gynecologic Cancer Center of Excellence, Annandale, VA, 6Mid Atlantic Pelvic Surgery Associates, Annandale, VA, 7Walter Reed National Military Medical Center, Bethesda, MD
 
See more of: Featured Poster Session V: Clinical Trials/Drug Repurposing
See more of: Featured Poster Session
<< Previous Presentation | Next Presentation >>